IP Library Granted Patent US 11,406,978
Granted Patent B2
US 11,406,978 · App. 16/434,194 · Granted Aug 9, 2022

Method for hemostasis testing

Inventors: Peter Delemico (Chicago, IL); Carlos G. Lopez-Espina (Evanston, IL); Gabriel Raviv (Glenview, IL)
Assignee: Haemonetics Corporation
B01L3/50273B01L3/502B01L3/502753G01N11/16G01N29/032G01N29/036G01N29/2418G01N33/4905B01L2300/0663B01L2300/0816B01L2300/0877B01L2300/165B01L2400/0433B01L2400/0481B01L2400/0487B01L2400/0638G01N2291/0251G01N2291/02466G01N2291/02818G01N2291/02827G01N2291/0427G01N2800/224
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,406,978
App. No.
16/434,194
Granted
Aug 9, 2022
Kind
B2
Abstract

A sample testing cartridge is usable to perform a variety of tests on a viscoelastic sample, such hemostasis testing on a whole blood or blood component sample. The cartridge includes a sample processing portion that is in fluid communication with a sample retention structure. A suspension, such as a beam, arm, cantilever or similar structure supports or suspends the sample retention portion relative to the sample processing portion in a unitary structure. In this manner, the sample retention portion may be placed into dynamic excitation responsive to excitation of the cartridge and correspondingly dynamic, resonant excitation of the sample contained within the sample retention portion, while the sample processing portion remains fixed. Observation of the excited sample yields data indicative of hemostasis. The data may correspond to hemostasis parameters such as time to initial clot formation, rate of clot formation, maximum clot strength and degree of clot lysis.

Claims (13)

1. A method of testing blood hemostasis comprising:

introducing a blood sample into a fluid processing structure, the fluid processing structure having a passage containing a reagent;

pre-processing at least a portion of the blood sample by passing the portion through the passage;

communicating the pre-processed portion to a sample retention structure portion of the fluid processing structure; and

testing the pre-processed portion to obtain data indicative of at least one hemostasis parameter, wherein testing the pre-processed portion to obtain data indicative of at least one hemostasis parameter comprises exciting the pre-processed portion to a resonant vibration state of the pre-processed portion.

2. The method of claim 1 , wherein pre-processing comprises passing the portion through the passage multiple times.

3. The method of claim 1 , wherein the fluid processing structure comprises a pump and wherein passing the portion through the passage comprises pumping the portion through the passage.

4. The method of claim 3 , wherein communicating the pre-processed portion to the sample retention apparatus comprises pumping the sample to the sample retention apparatus.

5. The method of claim 1 , the fluid processing structure comprising first and second passages, and pre-processing comprises passing a first portion of the blood sample through the first passage and passing a second portion of the blood sample through the second passage.

6. The method of claim 5 , comprising communicating the pre-processed first portion to a first sample retention structure portion and communicating the pre-processed second portion to a second sample retention structure portion, and simultaneously testing the pre-processed first portion to obtain a first hemostasis parameter, and testing the pre-processed second portion to obtain a second hemostasis parameter.

7. The method of claim 1 , wherein the hemostasis parameter comprises at least one of: time to initial clot formation, rate of clot formation, maximum clot strength and time to clot lysis.

8. The method of claim 1 , comprising communicating the data via a network.

9. The method of claim 1 , comprising graphically depicting the data.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2022
From: CORAMED TECHNOLOGIES, LLC
To: HAEMONETICS CORPORATION
Reel/Frame 059567/0684 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2021
From: CORAMED TECHNOLOGIES, LLC
To: HAEMONETICS CORPORATION
Reel/Frame 054870/0781 →
Continuity (5)
Division 15465490 · Mar 21, 2017
Continuation 14754550 · Jun 29, 2015
Continuation 14212788 · Mar 14, 2014
Provisional Application 61792349 · Mar 15, 2013
Related Publication 20190283020A1 · Sep 19, 2019